COVID-19 Reinfection Unlikely For At Least 6 Months, Study Finds

University of Oxford researchers say they have 'really good news' about short-term immunity.

11/22/2020 12:54:00 AM

University of Oxford researchers say they have 'really good news' about short-term immunity.

University of Oxford researchers say they have 'really good news' about short-term immunity.

Kate KellandLONDON, Nov 20 (Reuters) - People who’ve had COVID-19 are highly unlikely to contract it again for at least six months after their first infection, according to a British study of health care workers on the frontline of fight against the coronavirus pandemic.

Tony Hsieh, former Zappos CEO and 'tremendous visionary,' dies at 46 Iran's supreme leader vows revenge after top nuclear scientist apparently assassinated Ex-CIA head John Brennan calls Ted Cruz 'simple-minded' in Twitter row over Iran killing

The findings should offer some reassurance for the more than 51 million people worldwide who have been infected with the pandemic disease, researchers at the University of Oxford said.“This is really good news, because we can be confident that, at least in the short term, most people who get COVID-19 won’t get it again,” said David Eyre, a professor at Oxford’s Nuffield Department of Population Health, who co-led the study.

Isolated cases of re-infection with COVID-19, the disease caused by the SARS-CoV-2 virus, had raised concerns that immunity might be short-lived and that recovered patients may swiftly fall sick again.But the results of this study, carried out in a cohort of UK health care workers - who are among those at highest risk of contracting COVID-19 - suggest cases of reinfection are likely to remain extremely rare.

“Being infected with COVID-19 does offer protection agains tre-infection for most people for at least six months,” Eyre said. “We found no new symptomatic infections in any of the participants who had tested positive for antibodies.”The study, part of a major staff testing program, covered a 30-week period between April and November 2020. Its results have not peer-reviewed by other scientists but were published before review on the MedRxiv website.

During the study, 89 of 11,052 staff without antibodies developed a new infection with symptoms, while none of the 1,246staff with antibodies developed a symptomatic infection.Staff with antibodies were also less likely to test positive for COVID-19 without symptoms, the researchers said, with 76without antibodies testing positive, compared to only three with antibodies. Those three were all well and did not developCOVID-19 symptoms, they added.

“We will continue to follow this cohort of staff carefully to see how long protection lasts and whether previous infection affects the severity of infection if people do get infected again,” Eyre said. Read more: HuffPostWomen »

Spain's BBVA and Sabadell end tie-up talks, TSB up for sale

BBVA and Sabadell ended merger talks on Friday after they failed to agree on price, stalling a wave of Spanish bank tie-ups and putting Sabadell's loss-making British lender TSB on the block.